A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer. Patients with nonmetastatic prostate cancer who ...

Former U.S. President Joe Biden has been diagnosed with stage 4 metastatic prostate cancer, which has spread to his bones. Treatment for this type of prostate cancer can stall tumor growth, but at ...